TAG:
tumor marker test
Hospitals Recognize Need for Uniform Lab Test Data
CEO SUMMARY: Hospitals may soon insist that payers allow their in-house labs to provide outpatient testing regardless of exclusive managed care contracts with national lab companies. The migration to accountable care organizations (ACOs) and medical homes makes it essential that physician…
Bio-Reference Enters DNA Sequencing Market
CEOSUMMARY: Bio-Reference Laboratories has just placed an unexpected bet on the wide-open opportunities in genetic testing. The acquisition of GeneDX brings it a respected team of geneticists, capabilities in full DNA sequencing, and a proven track record in testing for rare and complex h…
CURRENT ISSUE
Volume XXVII, No. 15 – October 26, 2020
INDUSTRY LEADERS SHARE THEIR CONCERNS over CMS’ planned cuts to COVID-19 test payments and discuss their proposed strategies for COVID testing. Also, a pathology group reports lessons learned the hard way when it opened a brand-new clinical lab in the midst of the worst of the pandemic.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
